down arrow

Shanghai Rendu Biotechnology Co., Ltd.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000059K5
CNY
47.25
7.17 (17.89%)

Dec 05

SHG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Shanghai Rendu Biotechnology Co., Ltd.
Why is Shanghai Rendu Biotechnology Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 17.05%
  • The company has been able to generate a Return on Capital Employed (avg) of 17.05% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of -18.99% and Operating profit at -196.46% over the last 5 years
  • RAW MATERIAL COST(Y) Fallen by -3.58% (YoY)
  • PRE-TAX PROFIT(Q) At CNY -1.05 MM has Grown at 71.87%
  • NET PROFIT(Q) At CNY -0.39 MM has Grown at 76.29%
3
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 15.98%, its profits have fallen by -143.7%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Shanghai Rendu Biotechnology Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Shanghai Rendu Biotechnology Co., Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Shanghai Rendu Biotechnology Co., Ltd.
-100.0%
1.54
44.20%
China Shanghai Composite
15.19%
1.04
14.54%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-18.99%
EBIT Growth (5y)
-196.46%
EBIT to Interest (avg)
-6.82
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.84
Sales to Capital Employed (avg)
0.20
Tax Ratio
42.93%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
17.05%
ROE (avg)
2.04%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.54
EV to EBIT
-15.13
EV to EBITDA
-30.14
EV to Capital Employed
5.49
EV to Sales
3.55
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-36.27%
ROE (Latest)
-1.02%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company
RAW MATERIAL COST(Y)

Fallen by -3.58% (YoY

PRE-TAX PROFIT(Q)

At CNY -1.05 MM has Grown at 71.87%

NET PROFIT(Q)

At CNY -0.39 MM has Grown at 76.29%

-16What is not working for the Company
NET PROFIT(HY)

At CNY -8.97 MM has Grown at -148.01%

INTEREST(HY)

At CNY 0.17 MM has Grown at 27.89%

ROCE(HY)

Lowest at -1.1%

NET SALES(Q)

Lowest at CNY 40.38 MM

Here's what is working for Shanghai Rendu Biotechnology Co., Ltd.
Pre-Tax Profit
At CNY -1.05 MM has Grown at 71.87%
over average net sales of the previous four periods of CNY -3.75 MM
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit
At CNY -0.39 MM has Grown at 76.29%
over average net sales of the previous four periods of CNY -1.63 MM
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CNY MM)

Raw Material Cost
Fallen by -3.58% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Shanghai Rendu Biotechnology Co., Ltd.
Interest
At CNY 0.17 MM has Grown at 27.89%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Net Sales
Lowest at CNY 40.38 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (CNY MM)

Net Sales
At CNY 40.38 MM has Fallen at -8.42%
over average net sales of the previous four periods of CNY 44.09 MM
MOJO Watch
Near term sales trend is negative

Net Sales (CNY MM)

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."